CD4 and infection: Serial assessment of CD4 Tvis against adenovirus, cytomegalovirus, and herpes symplex virus allowed personalized steering of immunosuppressive therapy with a net reduction of the exposure to unnecessary overimmunosuppression, reduced infection events, and comparable kidney function [82].